Abstract:Background: Understanding genetic underpinnings of immune-mediated inflammatory diseases is crucial to improve treatments. Single-cell RNA sequencing (scRNA-seq) identifies cell states expanded in disease, but often overlooks genetic causality due to cost and small genotyping cohorts. Conversely, large genome-wide association studies (GWAS) are commonly accessible. Methods: We present a 3-step robust benchmarking analysis of integrating GWAS and scRNA-seq to identify genetically relevant cell states and genes in inflammatory diseases. First, we applied and compared the results of two recent algorithms based on networks (scGWAS) or single-cell disease scores (scDRS), according to accuracy/sensitivity and interpretability (M. J. Zhang et al. 2022; Jia et al. 2022). While previous studies focused on coarse cell types, we used disease-specific, fine-grained single-cell atlases (183,742 and 228,211 cells) and GWAS data (Ns of 97,1,73 and 45,975) for rheumatoid arthritis (RA) and ulcerative colitis (UC) (F. Zhang et al. 2023; Ishigaki et al. 2022; Smillie et al. 2019; de Lange et al. 2017). Second, given the lack of scRNA-seq for many diseases with GWAS, we further tested the tools' resolution limits by differentiating between similar diseases with only one fine-grained scRNA-seq atlas. Lastly, we provide a novel evaluation of noncoding SNP incorporation methods by testing which enabled the highest sensitivity/accuracy of known cell-state calls. Results: We first found that single-cell based tool scDRS called superior numbers of supported cell states, like MERTK+ myeloid cells in RA, which were overlooked by network-based scGWAS. While scGWAS was advantageous for gene exploration, scDRS captured cellular heterogeneity of disease-relevance without single-cell genotyping. For noncoding SNP integration, we found a key trade-off between statistical power and confidence with positional (e.g. MAGMA) and non-positional approaches (e.g. chromatin-interaction, eQTL). Even when directly incorporating noncoding SNPs through 5' scRNA-seq measures of regulatory elements, non disease-specific atlases gave misleading results by not containing disease-tissue specific transcriptomic patterns. Despite this criticality of tissue-specific scRNA-seq, we showed that scDRS enabled deconvolution of two similar diseases with a single fine-grained scRNA-seq atlas and separate GWAS. Indeed, we identified supported and novel genetic-phenotype linkages separating RA and ankylosing spondylitis, and UC and crohn's disease. Overall, while noting evolving single-cell technologies, our study provides key findings for integrating expanding fine-grained scRNA-seq, GWAS, and noncoding SNP resources to unravel the complexities of inflammatory diseases.

Polygenic Regression Uncovers Trait-Relevant Cellular Contexts Through Pathway Activation Transformation of Single-Cell RNA Sequencing Data

sc2GWAS: a comprehensive platform linking single cell and GWAS traits of human

Tracing the cell-type-specific modules of immune responses during COVID-19 progression using scDisProcema

Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics

Single-Cell Sequencing Insights into the Transcriptional Landscape of Parkinson's Disease

Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data

Disentangling associations between complex traits and cell types with

Deconvolution of polygenic risk score in single cells unravels cellular and molecular heterogeneity of complex human diseases

Leveraging single-cell ATAC-seq and RNA-seq to identify disease-critical fetal and adult brain cell types

Inferring relevant cell types for complex traits using single-cell gene expression

Single-cell based integrative analysis of transcriptomics and genetics reveals robust associations and complexities for inflammatory diseases

A Global Overview of Single-Cell Type Selectivity and Pleiotropy in Complex Diseases and Traits

Identifying Disease Related Sub-Pathways for Analysis of Genome-Wide Association Studies

Openness weighted association studies: leveraging personal genome information to prioritize non-coding variants

Cell-type-specific mapping of enhancers and target genes from single-cell multimodal data

Evaluating methods for integrating single-cell data and genetics to understand inflammatory disease complexity

CWAS-Plus: Estimating category-wide association of rare noncoding variation from whole-genome sequencing data with cell-type-specific functional data

Single-cell transcriptome-wide Mendelian randomization and colocalization analyses uncover cell-specific mechanisms in atherosclerotic cardiovascular disease

Genetic variants associated with cell-type-specific intra-individual gene expression variability reveal new mechanisms of genome regulation

The impact of cell type and context-dependent regulatory variants on human immune traits